table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies
stem cells Shu Shi
corticosteroids
dexamethasone DEXA-COVID19 CODEX ... Jamaati
Dexamethasone 12mg COVID STEROID 2
Hydrocortisone CAPE-COVID Munch ...
methylprednisolone Steroids-SARI
Immunostimulants drugs
convalescent plasma treatment CP-COVID-19 Li Rasheed O’Donnell PlasmAr CAPSID AlQahtani REMAP-CAP ... RECOVER Pouladzadeh Sekine ...
immunoglobulin therapy Tabarsi Raman
interferon
IFN beta-1a Darazam ... Kalil ...
IFN beta-1b Rahmani Darazam ...
neutralizing antibody
equine polyclonal antibodies INM005 Lopardo
Immunosuppressants drugs
adalimumab Fakharian
anti-interleukin-6
Levilimab V.Lomakin ...
sarilumab sarilumab Sanofi phase 3 outside US
sarilumab high dose (400mg) Lescure ...
sarilumab low dose (200mg) Lescure ...
tocilizumab MARIPOSA COVACTA ... CORIMUNO-TOCI-1 ... REMAP-CAP ... Veiga Talaschian CORIMUNO-TOCI-ICU ... Rosas ...
canakinumab CAN-COVID
janus kinase (JAK) inhibitor
baricitinib COV-BARRIER ...
ruxolitinib Cao
TD-0903
TD-0903 10mg Singh ...
TD-0903 1mg Singh ...
TD-0903 3mg Singh ...
Kinase inhibitors
imatinib Aman

6 studies excluded by filtering options 0

5317 Lu, 2020 1223not a RCThigh risk of bias
5453 Raef, 2020 1134not a RCThigh risk of bias
5454 Jianfeng, 2020 1133not a RCThigh risk of bias
5455 Tomasz, 2020 1204not a RCThigh risk of bias
5484 Salton (Methylprednisolone), 2020 0134selection pending
5614 Monreal, 2020 0130selection pending

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons